• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自我更新并不能预测高级别神经胶质瘤小鼠模型的肿瘤生长潜力。

Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma.

机构信息

Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Cancer Cell. 2012 Jan 17;21(1):11-24. doi: 10.1016/j.ccr.2011.11.025.

DOI:10.1016/j.ccr.2011.11.025
PMID:22264785
Abstract

Within high-grade gliomas, the precise identities and functional roles of stem-like cells remain unclear. In the normal neurogenic niche, ID (Inhibitor of DNA-binding) genes maintain self-renewal and multipotency of adult neural stem cells. Using PDGF- and KRAS-driven murine models of gliomagenesis, we show that high Id1 expression (Id1(high)) identifies tumor cells with high self-renewal capacity, while low Id1 expression (Id1(low)) identifies tumor cells with proliferative potential but limited self-renewal capacity. Surprisingly, Id1(low) cells generate tumors more rapidly and with higher penetrance than Id1(high) cells. Further, eliminating tumor cell self-renewal through deletion of Id1 has modest effects on animal survival, while knockdown of Olig2 within Id1(low) cells has a significant survival benefit, underscoring the importance of non-self-renewing lineages in disease progression.

摘要

在高级别神经胶质瘤中,干细胞样细胞的精确身份和功能角色仍不清楚。在正常的神经发生龛内,ID(DNA 结合抑制剂)基因维持成人神经干细胞的自我更新和多能性。使用 PDGF 和 KRAS 驱动的小鼠神经胶质瘤发生模型,我们表明高 Id1 表达(Id1(high))鉴定出具有高自我更新能力的肿瘤细胞,而低 Id1 表达(Id1(low))鉴定出具有增殖潜力但自我更新能力有限的肿瘤细胞。令人惊讶的是,Id1(low)细胞比 Id1(high)细胞更快且更易发生肿瘤。此外,通过删除 Id1 消除肿瘤细胞的自我更新对动物存活的影响不大,而在 Id1(low)细胞中敲低 Olig2 则具有显著的生存获益,这突显了非自我更新谱系在疾病进展中的重要性。

相似文献

1
Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma.自我更新并不能预测高级别神经胶质瘤小鼠模型的肿瘤生长潜力。
Cancer Cell. 2012 Jan 17;21(1):11-24. doi: 10.1016/j.ccr.2011.11.025.
2
Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.抑制 ID1-BMPR2 内源性信号使胶质瘤干细胞对分化治疗敏感。
Clin Cancer Res. 2018 Jan 15;24(2):383-394. doi: 10.1158/1078-0432.CCR-17-1529. Epub 2017 Dec 5.
3
The expression and roles of inhibitor of DNA binding helix-loop-helix proteins in the developing and adult mouse retina.DNA 结合螺旋-环-螺旋蛋白抑制剂在发育中和成年小鼠视网膜中的表达和作用。
Neuroscience. 2011 Feb 23;175:367-79. doi: 10.1016/j.neuroscience.2010.12.007. Epub 2010 Dec 9.
4
Inhibitor of DNA binding 1 (Id1) induces differentiation and proliferation of mouse embryonic carcinoma P19CL6 cells.DNA 结合抑制因子 1(Id1)诱导小鼠胚胎癌细胞 P19CL6 的分化和增殖。
Biochem Biophys Res Commun. 2011 Aug 26;412(2):253-9. doi: 10.1016/j.bbrc.2011.07.079. Epub 2011 Jul 28.
5
The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.分化抑制因子异构体 Id1b 通过选择性剪接产生,维持细胞静止状态,并赋予自我更新和癌症干细胞样特性。
Cancer Lett. 2015 Jan 28;356(2 Pt B):899-909. doi: 10.1016/j.canlet.2014.10.035. Epub 2014 Nov 6.
6
MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.微小 RNA-218 通过靶向多梳组基因 BMI1 抑制脑胶质瘤侵袭、迁移、增殖和肿瘤干细胞自我更新。
Cancer Res. 2013 Oct 1;73(19):6046-55. doi: 10.1158/0008-5472.CAN-13-0358. Epub 2013 Aug 15.
7
ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.ID1 和 ID3 通过 p21 调节人结肠癌起始细胞的自我更新能力。
Cancer Cell. 2012 Jun 12;21(6):777-92. doi: 10.1016/j.ccr.2012.04.036.
8
Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.Id1在转基因小鼠中的过表达促进乳腺基底干细胞活性和乳腺肿瘤发生。
Oncotarget. 2015 Jul 10;6(19):17276-90. doi: 10.18632/oncotarget.3640.
9
Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.重叠基因可能控制小鼠体细胞重编程为诱导多能干细胞(iPSC)以及乳腺癌干细胞的过程。
In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.
10
Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.血小板衍生生长因子(PDGF)和表皮生长因子(EGF)受体信号传导中依赖少突胶质细胞转录因子2(Olig2)的相互转变调节恶性胶质瘤的肿瘤表型和有丝分裂生长
Cancer Cell. 2016 May 9;29(5):669-683. doi: 10.1016/j.ccell.2016.03.027.

引用本文的文献

1
Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry.DNA结合抑制因子-1是癌细胞血管生成拟态的关键调节因子。
Mol Oncol. 2025 Sep;19(9):2537-2556. doi: 10.1002/1878-0261.70027. Epub 2025 Mar 21.
2
ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.ALDH1A3 有助于辐射诱导的自我更新抑制,并在 p53 缺陷型神经胶质瘤干细胞分化起始时促进其增殖活性。
Cells. 2024 Oct 31;13(21):1802. doi: 10.3390/cells13211802.
3
Nuclear Glycoprotein A Repetitions Predominant (GARP) Is a Common Trait of Glioblastoma Stem-like Cells and Correlates with Poor Survival in Glioblastoma Patients.
核糖蛋白A重复序列优势型(GARP)是胶质母细胞瘤干细胞样细胞的共同特征,且与胶质母细胞瘤患者的不良生存相关。
Cancers (Basel). 2023 Dec 5;15(24):5711. doi: 10.3390/cancers15245711.
4
Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14.针对癌症干细胞干性调控因子 PRDI-BF1 和 RIZ 结构域锌指蛋白 14 的治疗性 siRNA。
Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(7):325-335. doi: 10.2183/pjab.98.017.
5
Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.肿瘤细胞异质性和可塑性:胶质母细胞瘤的范式转变。
Neuro Oncol. 2022 May 4;24(5):669-682. doi: 10.1093/neuonc/noab269.
6
Id proteins: emerging roles in CNS disease and targets for modifying neural stemcell behavior.Id 蛋白:中枢神经系统疾病中的新角色和改变神经干细胞行为的靶点。
Cell Tissue Res. 2022 Mar;387(3):433-449. doi: 10.1007/s00441-021-03490-z. Epub 2021 Jul 24.
7
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.通过抗 SerpinB9 治疗实现直接肿瘤杀伤和免疫治疗。
Cell. 2020 Nov 25;183(5):1219-1233.e18. doi: 10.1016/j.cell.2020.10.045.
8
Transitional dynamics of cancer stem cells in invasion and metastasis.癌症干细胞在侵袭和转移中的过渡动力学。
Transl Oncol. 2021 Jan;14(1):100909. doi: 10.1016/j.tranon.2020.100909. Epub 2020 Oct 10.
9
Diversity of Clinically Relevant Outcomes Resulting from Hypofractionated Radiation in Human Glioma Stem Cells Mirrors Distinct Patterns of Transcriptomic Changes.人类胶质瘤干细胞中分割放疗导致的临床相关结果的多样性反映了转录组变化的不同模式。
Cancers (Basel). 2020 Mar 1;12(3):570. doi: 10.3390/cancers12030570.
10
Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma.肿瘤内异质性和基因表达的纵向变化预测新诊断和复发性胶质母细胞瘤的差异药物敏感性
Cancers (Basel). 2020 Feb 24;12(2):520. doi: 10.3390/cancers12020520.